CYP2E1 activity in patients with alcoholic liver disease
Authors:
- Jörg MetzlerJMJörg Metzler
- Johann Christian BodeJBJohann Christian Bode
- Ulrich KlotzUKUlrich Klotz
- 1 December 1997
- journal article
- Published by Elsevier in Journal of Hepatology
- Vol. 27 (6) , 1009-1014
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Polymorphism in the cytochrome P450 2E1 gene and the risk of alcoholic liver diseaseJournal of Hepatology, 1997
- Rsa I polymorphism at the cytochrome P4502E1 locus is not related to the risk of alcohol‐related severe liver diseaseLiver International, 1996
- Role of CYP2E1 in the Hepatotoxicity of AcetaminophenJournal of Biological Chemistry, 1996
- Human Hepatic Alcohol Dehydrogenase and Human Erythrocyte Catalase Do Not Metabolize the Cytochrome P‐4502E1 Substrate, ChlorzoxazoneAlcohol, Clinical and Experimental Research, 1996
- Genetic polymorphism of cytochrome P4502E1 and risk of alcoholic liver disease in CaucasiansPharmacogenetics, 1995
- Chlorzoxazone is metabolized by human CYP1A2 as well as by human CYP2E1Pharmacogenetics, 1995
- Interaction between two probes used for phenotyping cytochromes P4501A2 (caffeine) and P4502E1 (chlorzoxazone) in humansPharmacogenetics, 1995
- Both cytochromes P450 2E1 and 1A1 are involved in the metabolism of chlorzoxazoneChemical Research in Toxicology, 1993
- P450 EnzymesClinical Pharmacokinetics, 1992
- Transection of the oesophagus for bleeding oesophageal varicesBritish Journal of Surgery, 1973